Disease Info Card

Dentatorubral-pallidoluysian Atrophy

Information about Dentatorubral-pallidoluysian Atrophy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Dentatorubral-pallidoluysian Atrophy

Most recent studies have shown that Dentatorubral-pallidoluysian Atrophy shares some biological mechanisms with ataxia, ataxia-spinocerebellar, atrophy, cerebellar-ataxia, chorea, choreoathetosis, dementia, epilepsies-myoclonic, epilepsy, huntington-disease, machado-joseph-disease, muscular-atrophy, myoclonic-epilepsies-progressive, myoclonus, nerve-degeneration, nervous-system-disorder, neurodegenerative-disorders, pallidoluysian-degeneration, spinocerebellar-degeneration, trinucleotide-repeat-expansion.

Among the many pathways, these few ones have gauged particular interests from scientists studying Dentatorubral-pallidoluysian Atrophy, and have been seen in publications frequently: Aging, Autophagy, Cell Cycle, Cell Death, Cell Division, Embryo Development, Female Meiosis, Localization, Meiosis, Neuron Death, Nuclear Export, Nuclear Transport, Pathogenesis, Proteolysis, Reflex, Regulation Of Autophagy, Segmentation, Spermatogenesis, Translation, Transport

Quite a number of genes have been found to play important roles in Dentatorubral-pallidoluysian Atrophy, such as AR, ATN1, ATXN1, ATXN10, ATXN2, ATXN3, ATXN7, BAIAP2, CACNA1A, CASP3, FMR1, HTT, LY6E, PLEKHG4, PPP2R2B, SLC6A4, TBP. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.